With about 190,000 people in the UK living with the disease and 10,000 diagnosed annually, the early treatment method could ...

In a randomized trial, 1 day of octreotide infusion combined with endoscopic therapy proved noninferior to 5 days for acute ...

“There’s currently no cure for Crohn’s disease. There are a variety of therapies but none that work for everyone. Your ...

Following successful studies, the National Institute of Health and Care Excellence (NICE) has recommended a new drug for ...

In a new study led by researchers at Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania (Penn Medicine) researchers defined key ...

In patients with Crohn's disease (CD) who underwent ileocolic resection (ICR), preoperative myosteatosis (high lipid content in skeletal muscles) was associated with postoperative complications; low ...

The rollout of a drug recommended by the National Institute of Health and Care Excellence is 'really exciting' news for UK ...

Crohn's disease and ulcerative colitis. Here's how to tell which one you have.

DelveInsight’s “Crohn's Disease Market Insights, Epidemiology, and Market Forecast–2034” provides a comprehensive analysis of ...

The first global consensus on inflammatory bowel disease and pregnancy delivers clinician-focused, evidence-based guidance for real-world practice.

Risk for venous thromboembolism (VTE) after an operation for colorectal cancer (CRC) is higher among patients with inflammatory bowel disease (IBD), according to results of a population-based cohort ...